NO963329D0 - Diastereomert rene trifluormetylketonpeptid-derivater som inhibitorer for human leukocytelastase - Google Patents

Diastereomert rene trifluormetylketonpeptid-derivater som inhibitorer for human leukocytelastase

Info

Publication number
NO963329D0
NO963329D0 NO963329A NO963329A NO963329D0 NO 963329 D0 NO963329 D0 NO 963329D0 NO 963329 A NO963329 A NO 963329A NO 963329 A NO963329 A NO 963329A NO 963329 D0 NO963329 D0 NO 963329D0
Authority
NO
Norway
Prior art keywords
inhibitors
human leukocyte
peptide derivatives
diastereomerically pure
leukocyte elastase
Prior art date
Application number
NO963329A
Other languages
English (en)
Other versions
NO963329L (no
NO313882B1 (no
Inventor
Stephen John Pegg
George Joseph Sependa
Elwyn Peter Davies
Chris Allan Veale
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421550A external-priority patent/GB9421550D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO963329D0 publication Critical patent/NO963329D0/no
Publication of NO963329L publication Critical patent/NO963329L/no
Publication of NO313882B1 publication Critical patent/NO313882B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19963329A 1994-02-11 1996-08-09 Diastereomert rene trifluormetylketonpeptidderivater som inhibitorer for human leukocyttelastase og fremstilling avderivatene NO313882B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9402680A GB9402680D0 (en) 1994-02-11 1994-02-11 Pyrrolidine derivatives
GB9421550A GB9421550D0 (en) 1994-10-26 1994-10-26 Heterocyclic derivative
PCT/GB1995/000242 WO1995021855A1 (en) 1994-02-11 1995-02-07 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase

Publications (3)

Publication Number Publication Date
NO963329D0 true NO963329D0 (no) 1996-08-09
NO963329L NO963329L (no) 1996-10-09
NO313882B1 NO313882B1 (no) 2002-12-16

Family

ID=26304315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19963329A NO313882B1 (no) 1994-02-11 1996-08-09 Diastereomert rene trifluormetylketonpeptidderivater som inhibitorer for human leukocyttelastase og fremstilling avderivatene

Country Status (19)

Country Link
US (3) US5739157A (no)
EP (1) EP0743953B1 (no)
JP (1) JP3416142B2 (no)
CN (1) CN1140455A (no)
AT (1) ATE174034T1 (no)
AU (1) AU692515B2 (no)
CA (1) CA2180006A1 (no)
DE (1) DE69506380T2 (no)
DK (1) DK0743953T3 (no)
ES (1) ES2125004T3 (no)
FI (1) FI963132L (no)
GB (1) GB9402680D0 (no)
IL (1) IL112613A (no)
MX (1) MX9603291A (no)
NO (1) NO313882B1 (no)
NZ (1) NZ279265A (no)
TW (1) TW414801B (no)
WO (1) WO1995021855A1 (no)
YU (1) YU7195A (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
GB9502152D0 (en) * 1995-02-03 1995-03-29 Zeneca Ltd Proline derivatives
AU7261196A (en) * 1995-10-10 1997-04-30 Eli Lilly And Company N-{2-substituted-3-(2-aminoethyl)-1h-indol-5-yl}-amides: new 5-ht1f agonists
EA001437B1 (ru) * 1996-03-28 2001-02-26 Глаксо Груп Лимитед Производные пирролопирролона в качестве ингибиторов нейтрофильной эластазы
GB9719172D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9719187D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
PE107899A1 (es) * 1997-09-09 1999-11-17 Glaxo Group Ltd Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
WO2004024701A1 (en) 2002-09-10 2004-03-25 Bayer Healthcare Ag Heterocyclic derivatives
ES2367699T3 (es) 2004-02-19 2011-11-07 Bayer Pharma Aktiengesellschaft Derivados de dihidropiridinona.
DE102005037791A1 (de) * 2005-08-10 2007-02-15 Ernst-Moritz-Arndt Universität Greifswald Verwendung von spezifischen Trifluormethylketonen zur Vorbeugung und Behandlung einer Pankreatitis
CN101534824A (zh) * 2006-11-17 2009-09-16 艾博特公司 作为化学活素受体拮抗剂的氨基吡咯烷
CN103226756A (zh) * 2013-04-28 2013-07-31 文俊 工艺品生产过程的工艺制作及生产过程的记录方法和系统
WO2021053058A1 (en) 2019-09-17 2021-03-25 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
LT4106757T (lt) 2020-04-16 2023-11-10 Mereo Biopharma 4 Limited Neutrofilų elastazės inhibitoriaus alvelestato panaudojimas kvėpavimo sistemos ligų, nulemtų alfa-1 antitripsino nepakankamumo, gydymui
JP2024540952A (ja) 2021-10-20 2024-11-06 メレオ バイオファーマ ４ リミテッド 線維化の治療における使用のための好中球エラスターゼ阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
US5194588A (en) * 1985-01-22 1993-03-16 Ici Americas Inc. Aminoalcohol intermediates for peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives

Also Published As

Publication number Publication date
YU7195A (sh) 1998-09-18
IL112613A0 (en) 1995-05-26
CN1140455A (zh) 1997-01-15
AU692515B2 (en) 1998-06-11
JPH09508902A (ja) 1997-09-09
EP0743953B1 (en) 1998-12-02
US5739157A (en) 1998-04-14
NZ279265A (en) 1998-01-26
GB9402680D0 (en) 1994-04-06
NO963329L (no) 1996-10-09
ES2125004T3 (es) 1999-02-16
HK1011033A1 (en) 1999-07-02
FI963132A7 (fi) 1996-08-09
TW414801B (en) 2000-12-11
DK0743953T3 (da) 1999-08-16
FI963132A0 (fi) 1996-08-09
DE69506380D1 (de) 1999-01-14
AU1583995A (en) 1995-08-29
JP3416142B2 (ja) 2003-06-16
EP0743953A1 (en) 1996-11-27
IL112613A (en) 2000-02-29
CA2180006A1 (en) 1995-08-17
DE69506380T2 (de) 1999-05-06
US6037363A (en) 2000-03-14
ATE174034T1 (de) 1998-12-15
WO1995021855A1 (en) 1995-08-17
NO313882B1 (no) 2002-12-16
MX9603291A (es) 1997-02-28
FI963132L (fi) 1996-08-09
US5907043A (en) 1999-05-25

Similar Documents

Publication Publication Date Title
NO963329L (no) Diastereomert rene trifluormetylketonpeptid-derivater som inhibitorer for human leukocytelastase
DE69314169D1 (de) Peptide mit eine alphaaminoboronaire gruppe and ihre verwendung als elastasehemmer
NO943910D0 (no) Laktam-peptider med HLE-hemmende virkning
DE69931393D1 (de) Antithrombotische amide
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
EA199800620A1 (ru) Замещенные n-[(аминоиминометил или аминометил)фенил] пропиламиды
ATE527261T1 (de) 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
NO943909D0 (no) Laktam-dipeptider som har HLE-inhiberende aktivitet
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
MY136859A (en) Pyrrolidine derivatives as factor xa inhibitors
DE69321121D1 (de) Fluorenthaltende dipeptide als inhibitoren gegen elastase menschliches leukocyten
RU94046270A (ru) Лактамовые дипептиды, обладающие ингибирующей активностью по отношению к эластазе лейкоцитов человека, способ получения, фармацевтическая композиция
AU622316B2 (en) Fluoro-amide derivatives
DK0399688T3 (da) Trifluorketopeptidderivater, som er nyttige som human leukocyt-elastaseinhibitorer
EA200100477A1 (ru) Фармацевтическая композиция тнр и эналаприла
EA200400709A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
ATE355287T1 (de) 2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten
DE60321700D1 (de) Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten
LV12459A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
UY25369A1 (es) Procedimiento para preparar inhibidores de proteasa

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees